Fundacion GESICA
Quick facts
Marketed products
- Aspirin + Atorvastatin · Cardiovascular
This combination reduces cardiovascular risk by inhibiting platelet aggregation (aspirin) and lowering LDL cholesterol (atorvastatin).
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: